Why State Laws Matter Beyond HIPAA
HIPAA preempts state law only where state law is less protective — it does not preempt more stringent state requirements. For data categories that HIPAA does not cover (health information collected outside the traditional healthcare system, including via SMS lead intake, websites, and wellness apps), state consumer health privacy laws fill the gap entirely. A nationally-marketed Medicare program that collects health-related data from consumers in multiple states must comply with the most protective state law applicable to each consumer — in addition to HIPAA. As of mid-2026, at least seven states have enacted consumer health data laws or broad privacy laws with strong health data provisions.
The practical trigger is straightforward: if your Medicare program collects any data that could be characterized as "consumer health data" — including Medicare eligibility status, health conditions, current medication, or even healthcare-seeking behavior — from residents of states with consumer health data laws, those laws apply. You cannot opt out of state law by choosing not to serve a particular state, unless you technically restrict access (which is operationally impractical for SMS programs).
The HIPAA preemption framework
Under 45 CFR § 160.203, HIPAA's privacy standards preempt "contrary" state law — but only where state law is less protective of individual privacy. State laws that impose more protective requirements are not preempted and must be followed alongside HIPAA. This creates a patchwork compliance obligation: federal floor (HIPAA) plus the highest applicable state ceiling for each consumer's state of residence.
Who is affected
Any organization that: (1) collects health-related data from individuals who are residents of states with consumer health data laws, AND (2) is not covered by a HIPAA exemption in the applicable state law for that specific data. This includes lead generation companies, marketing platforms, Medicare broker organizations, general agents, and technology vendors — including those that are not HIPAA covered entities in the traditional sense.
Washington: My Health My Data Act (MHMDA)
Washington's MHMDA is the most comprehensive state consumer health data law enacted as of mid-2026. It requires opt-in consent before collecting consumer health data, prohibits geofencing near healthcare facilities, requires data processing agreements with third parties, and includes a private right of action. It applies extraterritorially to any organization that collects health data of Washington residents. For Medicare programs, MHMDA's consent requirement must be satisfied before any health-related data is collected via intake flows that reach Washington residents.
- Effective: July 23, 2023 (large entities); March 31, 2024 (small businesses)
- Statute: WA ESHB 1155; codified at RCW chapter 70.372
- Consent standard: Opt-in before any consumer health data collection
- Private right of action: Yes — individuals can sue directly
- Geofencing prohibition: Yes — 2,000 feet from healthcare facilities
- Extraterritorial: Yes — applies to any entity collecting WA consumer health data
- HIPAA exemption: Partial — covers PHI held by covered entities; broader data categories are not exempt
See the dedicated Washington MHMDA guide for full analysis.
Nevada: Consumer Health Data Privacy Law (SB 370)
Nevada SB 370, effective October 1, 2023, is the second health-specific state consumer privacy law in the US. It closely mirrors Washington's MHMDA in structure — opt-in consent, data processing agreements, consumer rights — but with a narrower definition of consumer health data and no private right of action. Enforcement is by the Nevada Attorney General. Like MHMDA, it applies extraterritorially to any organization collecting health data of Nevada residents.
- Effective: October 1, 2023
- Statute: Nevada SB 370 (2023 Session); codified at NRS chapter 629
- Consent standard: Opt-in before collecting consumer health data
- Private right of action: No — AG enforcement only
- Data definition: Consumer health data — narrower than MHMDA but still broader than HIPAA PHI
- Extraterritorial: Yes — applies to entities collecting data of Nevada residents
- HIPAA exemption: Yes for HIPAA-covered PHI; non-PHI health data is within scope
Key differences from MHMDA
Nevada SB 370 does not include MHMDA's geofencing prohibition or the same breadth of "healthcare-seeking behavior" in its data definition. Nevada's definition focuses more narrowly on data that directly reveals a health condition, whereas MHMDA also covers data that could be used to infer a health condition. Both laws require opt-in consent and data processing agreements, making MHMDA-compliant consent language generally sufficient for Nevada as well.
California: CPRA Sensitive Personal Information
California's Privacy Rights Act (CPRA) classifies health and medical information, as well as genetic data, as "sensitive personal information" (SPI). California consumers have enhanced rights over SPI: they can direct businesses to limit the use of their SPI to purposes necessary for the primary service, and they have the right to opt out of its sale or sharing. CPRA does not impose opt-in consent for health data collection (unlike MHMDA and NV SB 370), but it requires explicit notice and opt-out mechanisms. HIPAA-covered entities are largely exempt from CPRA for PHI, but non-covered-entity Medicare marketing organizations are subject to CPRA for California residents' health data.
- Effective: January 1, 2023
- Statute: California Civil Code § 1798.100 et seq. (CCPA as amended by Prop 24)
- Consent standard: No opt-in required; opt-out of sale/sharing and right to limit SPI use
- Private right of action: Limited — only for data breaches involving personal information; general violations are AG/CPPA enforcement
- Market size consideration: Largest state population in the US — CPRA compliance is essential for any national program
- HIPAA exemption: For PHI held by covered entities and BAs; broader health data is within scope
CPRA's "limit use" right for health data
Under California Civil Code § 1798.121, consumers may direct a business to limit its use of sensitive personal information — including health data — to uses necessary to provide the requested service. Businesses must honor this request and provide a clear mechanism (typically a link saying "Limit the Use of My Sensitive Personal Information") for California residents. Medicare programs must include this mechanism in their privacy notices and web interfaces.
Colorado: Colorado Privacy Act (CPA)
Colorado's Privacy Act (CPA), effective July 1, 2023, classifies health data as sensitive personal data and requires opt-in consent before collecting or processing it. The CPA applies to controllers that collect data of 100,000 or more Colorado residents annually, or 25,000+ residents where data is sold or shared for commercial benefit. It is enforced by the Colorado Attorney General, with no private right of action. For Medicare programs with meaningful Colorado exposure, CPA's opt-in consent requirement for health data is the primary obligation to address.
- Effective: July 1, 2023
- Statute: CRS § 6-1-1301 et seq. (Colorado Privacy Act)
- Threshold: 100,000 CO residents/year or 25,000 where data is sold
- Consent standard: Opt-in for sensitive data (including health data)
- Private right of action: No — AG enforcement only
- HIPAA exemption: Yes for PHI held by covered entities
State-by-State Comparison Table
Seven states have enacted laws with meaningful health data obligations beyond HIPAA as of mid-2026. Washington and Nevada have health-specific laws with opt-in consent. California, Colorado, Connecticut, and Virginia have general privacy laws with strong health data provisions. Texas has a broader-than-HIPAA health privacy law predating the current wave. The table below summarizes the key dimensions for Medicare program compliance planning.
| State | Law | Effective | Consent for Health Data | Private Right of Action | HIPAA Exemption | Extraterritorial |
|---|---|---|---|---|---|---|
| Washington | MHMDA (ESHB 1155) | Jul 2023 | Opt-in | Yes | Partial | Yes |
| Nevada | SB 370 (NRS 629) | Oct 2023 | Opt-in | No | Partial | Yes |
| California | CPRA (Civil Code §1798) | Jan 2023 | Opt-out / Limit | Breach only | Partial | Yes |
| Colorado | CPA (CRS §6-1-1301) | Jul 2023 | Opt-in | No | Yes (PHI) | Yes |
| Connecticut | CTDPA (PA 22-15) | Jul 2023 | Opt-in | No | Yes (PHI) | Yes |
| Virginia | VCDPA (§59.1-571) | Jan 2023 | Opt-in | No | Yes (PHI) | Yes |
| Texas | HB 300 (HSC §181) | 2012 (amended) | Consent required | Yes | Partial | Yes |
Table reflects major enacted state laws with health data provisions as of June 2026. State laws evolve; verify current requirements with legal counsel before relying on this summary.
Priority Framework for Medicare Programs
The most efficient compliance approach for a nationally-marketed Medicare program: build consent flows and data handling practices to Washington MHMDA and Nevada SB 370 standards — the most demanding currently enacted frameworks. MHMDA's opt-in consent, data processing agreement requirements, and consumer rights framework exceeds the requirements of most other state laws. A program compliant with MHMDA will generally satisfy CO CPA, CT CTDPA, and VA VCDPA with minimal additional customization. California CPRA requires specific "Limit the Use of My SPI" mechanisms in addition to MHMDA compliance — those should be added for California-facing interfaces.
Primary Sources
leg.state.nv.us → NV SB 370 (PDF)
leginfo.legislature.ca.gov → CA Civil Code §1798.100
ecfr.gov → 45 CFR § 160.203